Ekso Bionics to Report Third Quarter 2015 Highlights on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ekso Bionics to Report Third Quarter 2015 Highlights on Thursday, November 5th, 2015

RICHMOND, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss financial results for its third quarter, 2015, and provide a general business update on Thursday, November 5th, 2015 at 4:30pm ET.

Conference call and webcast details: Date: November 5th, 2015 Time: 4:30pm ET Listen via Internet: http://eksobionics.equisolvewebcast.com/q3-2015 Toll-free (US and Canada): 877-407-3036 International: 201-378-4919 A webcast replay will be available on the Ekso Bionics website for 30 days.

About Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO. To learn more about Ekso Bionics please visit us at www.eksobionics.com

Facebook: www.facebook.com/eksobionics

Twitter: @eksobionics

YouTube: http://www.youtube.com/user/EksoBionics/

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of human exoskeletons, (ii) a projection of financial results, financial condition, capital expenditures, capital structure or other financial items, (iii) the Company's future financial performance and (iv) the assumptions underlying or relating to any statement described in points (i), (ii) or (iii) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain adequate financing to fund the Company's operations and necessary to develop or enhance our technology, the significant length of time and resources associated with the development of the Company's products, the Company's failure to achieve broad market acceptance of the Company's products, the failure of our sales and marketing organization or partners to market our products effectively, adverse results in future clinical studies of the Company's medical device products, the failure to obtain or maintain patent protection for the Company's technology, failure to obtain or maintain regulatory approval to market the Company's medical devices, lack of product diversification, existing or increased competition, and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. The Company does not undertake to update these forward-looking statements.

Media Contact: Heidi Darling, Director of Marketing Communications Phone: 510-984-1761 x317 E-mail: Investor Contact: Chad Rubin, Senior Vice President Phone: 646-378-2947 E-mail:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 104

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 73

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 99

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
Winter Leaks Can Lock In Tarrant Sewer Costs for 2027

Updated Category News Views 86

Silent toilet seepage has a nasty habit of turning winter into a twelve-month utility hangover. Tarrant County homeowners are heading into the period when some local cities use household water consumption to calculate residential sewer charges for the following year. That is not the sort of detail anybody enjoys thinking about during the holidays, but ignoring it can be...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 90

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 22

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Century Lithium Clears a Crucial Nevada Permit Gate

Updated Category News Views 24

Permitting news rarely rings a cash register, but it can stop one from being bolted shut. Century Lithium has received confirmation from the Bureau of Land Management’s Tonopah Field Office that baseline studies for its wholly owned Angel Island lithium project in Esmeralda County, Nevada, are complete. The agency also set the project on the Environmental Impact...

Continue Reading
GFT's Banking Leader Tag Puts Execution Risks Into Focus

Updated Category News Views 82

A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...

Continue Reading
HLRBO's Data-Heavy Rebuild Changes Hunting Lease Market

Updated Category News Views 95

A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...

Continue Reading

Top 5 Most Recently Viewed Articles

Yourway Learning Raises $9 Million for Innovative AI Solutions

Updated Category News Views 261

Yourway Learning Secures $9 Million in Funding Yourway Learning has successfully closed a $9 million equity funding round, a significant boost aimed at pushing forward its mission of enhancing K-12 education through innovative AI solutions. The company's focus is on providing trusted, teacher-centered technology that addresses the unique challenges of modern educational...

Continue Reading
Investors Complain: Oddity Tech Ltd. Faces Class Action Allegations

Updated Category News Views 97

Concerns for Investors of Oddity Tech Ltd. Oddity Tech Ltd. (NASDAQ: ODD) is currently under scrutiny. Rosen Law Firm, a prominent global law firm focused on protecting investor rights, has alerted shareholders about a class action lawsuit that has been filed on their behalf. This lawsuit includes all individuals who bought Oddity's securities within a specific timeline,...

Continue Reading
Critical Update on aTyr Pharma's Securities Class Action

Updated Category News Views 219

Understanding the Class Action Lawsuit Against aTyr Pharma Investors should be aware of an ongoing securities class action lawsuit involving aTyr Pharma, Inc. (NASDAQ: ATYR), which highlights the importance of understanding legal proceedings that may impact financial interests. This lawsuit has garnered attention due to its implications for shareholders who acquired...

Continue Reading
Ping An Good Doctor's Robust Growth and Future Strategies Unveiled

Updated Category News Views 303

Ping An Good Doctor's Impressive Interim Performance Ping An Healthcare and Technology Company Limited (Stock Code: 1833.HK) has released its interim results, showcasing a remarkable performance for the first half of 2025. The company has reported total revenue reaching RMB2.5 billion, which reflects a substantial year-on-year increase of 19.5%. Moreover, the net profit...

Continue Reading
Revolutionizing Road Safety: The All-New Auto Air Pump

Updated Category News Views 171

Introducing the Auto Air Pump: A Solution for Flat Tires In an ever-evolving world where travel plays a vital role, ensuring safe and reliable journeys is of utmost importance. Few events are as frustrating as dealing with a flat tire, especially when help is far away. The Auto Air Pump has been designed to address this issue effectively. This compact yet powerful tire...

Continue Reading